Jayatma Enterprises Ltd — Updates, 13-08-2025: Company Update

Jayatma Enterprises has announced its 45th Annual General Meeting on Friday, September 5, 2025, at 11:30 AM IST via Video Conferencing/OAVM. The company's share transfer books will be closed from August 30 to September 5, 2025. Shareholders can cast their votes remotely, with the e-voting period open from September 2 to September 4, 2025. The cut-off date for e-voting eligibility is August 29, 2025. This meeting is crucial for shareholders to participate in company decisions.

Super Bakers (India) Limited has announced that its Board of Directors has approved the financial results for the quarter ended June 30, 2025. The unaudited results, along with the limited review report, are available on the company's website and the stock exchange's website. This update provides stakeholders with an overview of the company's performance for the latest quarter.

Minaxi Textiles has announced its 30th Annual General Meeting on Thursday, September 25, 2025, at 02:00 PM IST, to be held via Video Conferencing/OAVM. Shareholders will have the opportunity to participate and vote electronically. Separately, the company's Board of Directors has approved the financial results for the quarter ended June 30, 2025. These results, along with the Annual Report, are accessible on the company's website, offering key insights into the company's latest performance.

Indo US Bio-Tech Limited has announced its financial results for the quarter ended June 30, 2025. The company reported a total income from operations of ₹30.77 Cr, with a net profit of ₹4.70 Cr for the period. The profit before tax stood at ₹4.82 Cr. Earnings Per Share (EPS) for the quarter was ₹2.35. These figures provide a clear picture of the company's financial performance.

Royale Manor Hotels and Industries has announced its financial results for the quarter ended June 30, 2025. The company reported a total income from operations of ₹4.75 Cr. The net profit after tax for the period stood at approximately ₹0.01 Cr, with profit before tax at about ₹0.02 Cr. Earnings Per Share (EPS) for the quarter was ₹0.01. These results reflect the company's performance and financial position for the recent quarter.

Remedium Lifecare has reported a robust turnaround, with its Q1 FY26 net profit reaching ₹4.65 Cr, significantly exceeding the entire FY25 profit of ₹2.13 Cr and recovering from a previous quarter's loss. Revenue from operations for the quarter stood at ₹113.37 Cr, with profit before tax at ₹5.71 Cr. The company is poised for continued growth, focusing on expanding its R&D into key therapeutic areas and strengthening CDMO services to drive innovation and improve margins.

Brokerage firms Axis Capital, ICICI Securities, and Motilal Oswal see significant upside for Signature Global, setting price targets up to ₹1,780. This outlook follows the company's strong Q1 FY26 performance, where revenue more than doubled to ₹870 crore, and net profit surged five-fold to ₹34.4 crore. Signature Global recorded sales bookings of ₹2,640 crore and aims for ₹12,500 crore for FY26. Their business model focuses on efficient project completion and reinvestment.